Compare Abbott Laboratories (ABT) vs Indonesia Energy Corporation Limited (INDO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Indonesia Energy Corporation Limited — how do they compare? Abbott Laboratories trades at $95.13 (market cap $166.94B), while Indonesia Energy Corporation Limited trades at $2.86 (market cap $44.31M). The key difference: Abbott Laboratories is far larger — about 3767.5× Indonesia Energy Corporation Limited's market cap, and Abbott Laboratories pays a 2.63% dividend while Indonesia Energy Corporation Limited pays none. Which is the better fit depends on your goals.
| ABT | INDO | |
|---|---|---|
Market Cap | $166.94B | $44.31M |
Sector | Health | Energy |
52-Week High | $136.62 | $6.74 |
52-Week Low | $82.57 | $2.49 |
Enterprise Value | $193.69B | $39.69M |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
INDO trades at $2.79 with no recent price movement. The stock shows mixed technical signals with a bullish overall rating but bearish moving averages. Fundamentally, the company reported negative profitability metrics with a -253.4% net income margin on $2M revenue in 2025, though recent news highlights operational progress with new well drilling at the Kruh Block. Analyst consensus is unanimously bullish with 3 buy ratings.
The outlook hinges on successful execution of drilling operations to improve financial performance. Key opportunities include potential revenue growth from new wells, while risks center on continued negative cash flow and profitability challenges. The stock presents speculative potential for investors betting on operational turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Indonesia Energy Corporation Limited
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →
